HCmed Innovations Co (TPE:6934) ROCE %: 8.60% (As of Dec. 2025)


TPE:6934 HCmed Innovations Co Ltd TPE:6934
11 GF Score
Price NT$68.00
! 4 Warning Signs
View Full Analysis

What is HCmed Innovations Co ROCE %?

HCmed Innovations Co TPE:6934 -2.16% 11 ROCE % is 8.60% as of Dec. 2025. GuruFocus rates TPE:6934 with a GF Score™ of 11/100. The stock has 4 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. HCmed Innovations Co's annualized ROCE % for the quarter that ended in Dec. 2025 was 8.60%.

HCmed Innovations Co  (TPE:6934) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

HCmed Innovations Co ROCE % Related Terms

HCmed Innovations Co ROCE % Historical Data

* Premium members only.

The historical data trend for HCmed Innovations Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HCmed Innovations Co ROCE % Chart

HCmed Innovations Co Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
-57.71 -112.51 -70.40 -20.29 -42.72

HCmed Innovations Co Quarterly Data
Dec21 Dec22 Jun23 Dec23 Jun24 Sep24 Dec24 Jun25 Sep25 Dec25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only -37.88 71.57 0.00 -43.13 8.60
TPE:6934
11GF Score
HCmed Innovations Co Ltd TPE:6934
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

HCmed Innovations Co ROCE % Calculation

HCmed Innovations Co's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=-127.202/( ( (246.79 - 32.744) + (441.189 - 59.769) )/ 2 )
=-127.202/( (214.046+381.42)/ 2 )
=-127.202/297.733
=-42.72 %

HCmed Innovations Co's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Sep. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Sep. 2025 )(Q: Dec. 2025 )
=30.052/( ( (354.657 - 37.119) + (441.189 - 59.769) )/ 2 )
=30.052/( ( 317.538 + 381.42 )/ 2 )
=30.052/349.479
=8.60 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 8.60% mean?
HCmed Innovations Co (TPE:6934) has a ROCE % of 8.60% as of Dec. 2025.
Is HCmed Innovations Co's ROCE % too high?
HCmed Innovations Co's current ROCE % is 8.60%. The Medical Devices & Instruments industry median ROCE % is 2.19. HCmed Innovations Co's value of 8.60% is 292.7% above this industry median. Overall, HCmed Innovations Co has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does HCmed Innovations Co's ROCE % compare to ABT and SYK?
HCmed Innovations Co's ROCE % of 8.60% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.19. HCmed Innovations Co's value of 8.60% is 292.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Devices & Instruments company?
The median ROCE % among Medical Devices & Instruments companies is 2.19, based on 814 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. HCmed Innovations Co's current ROCE % of 8.60% is 292.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. HCmed Innovations Co's current ROCE % is 8.60%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HCmed Innovations Co stock overvalued right now?
HCmed Innovations Co (TPE:6934) has a current ROCE % of 8.60%. The current ROCE % is 8.60% and 292.7% above the Medical Devices & Instruments industry median of 2.19. HCmed Innovations Co's overall GF Score™ is 11/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For HCmed Innovations Co (TPE:6934), the current ROCE % is 8.60% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

HCmed Innovations Co Business Description

Address Dunhua S. Road, Rm.B, 10th floor., No.319, Sec.2, Taipei, TWN, 106033
HCmed Innovations Co Ltd is engaged in designing, developing, manufacturing and selling drug delivery system. It is focused on inhalation therapy to create integrated drug nebulizer combination products featuring nebulization therapeutic drugs that include small molecule synthetics and large molecule biologics, as either solutions, suspensions, and even difficult-to-deliver high viscosity drugs. Its product includes Pulmogine. Geographically, the company operates in America, Europe, Asian and African regions.
11GF Score

Get the complete analysis for TPE:6934

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$68.00
Price